Pharmacological blockade of protease-Activated Receptor 2 improves airway remodeling and lung inflammation in experimental allergic asthma. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2023. DOI: 10.1590/s2175-97902022e201089. Disponível em: https://periodicos.usp.br/bjps/article/view/207714.. Acesso em: 2 jun. 2024.